# SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc. is a company headquartered in Stamford, CT, United States.

## Company overview

- **Legal name:** SpringWorks Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Stamford, CT, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001773427

## About

SpringWorks Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001773427, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-02-20, it reported annual revenue of USD 191,589,000; net income of USD -258,131,000; total assets of USD 587,276,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $191.6M (USD 191,589,000)
- **Net income:** -$258.1M (USD -258,131,000)
- **Total assets:** $587.3M (USD 587,276,000)
- **Cash and equivalents:** $69.8M (USD 69,751,000)
- **Operating cash flow:** -$175.6M (USD -175,599,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $5.4M (USD 5,447,000)
- **Net income:** -$325.1M (USD -325,104,000)
- **Total assets:** $725.8M (USD 725,788,000)
- **Cash and equivalents:** $176.1M (USD 176,053,000)
- **Operating cash flow:** -$222.8M (USD -222,795,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$277.4M (USD -277,417,000)
- **Total assets:** $630.2M (USD 630,242,000)
- **Cash and equivalents:** $67.5M (USD 67,490,000)
- **Operating cash flow:** -$161.6M (USD -161,563,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$173.9M (USD -173,910,000)
- **Total assets:** $452.5M (USD 452,494,000)
- **Cash and equivalents:** $104.0M (USD 103,961,000)
- **Operating cash flow:** -$127.9M (USD -127,877,000)

## Recent SEC filings

- Form 8-K — filed 2025-07-01 — period 2025-07-01 — FORM 8-K
- Form 8-K — filed 2025-06-26 — period 2025-06-26 — FORM 8-K
- Form 8-K — filed 2025-06-16 — period 2025-06-13 — FORM 8-K
- Form 8-K — filed 2025-05-14 — period 2025-05-14 — FORM 8-K
- Form 10-Q — filed 2025-05-09 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-04-28 — period 2025-04-27 — FORM 8-K
- Form DEF 14A — filed 2025-04-04 — period 2025-05-14 — DEF 14A
- Form 10-K — filed 2025-02-20 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-02-20 — period 2025-02-20 — 8-K
- Form 8-K — filed 2025-02-12 — period 2025-02-11 — FORM 8-K
- Form 8-K — filed 2025-01-13 — period 2025-01-13 — FORM 8-K
- Form 10-Q — filed 2024-11-12 — period 2024-09-30 — 10-Q

---

Updated: 2026-10-23T20:13:49Z

Canonical page: https://altss.com/profile/springworks-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology